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Abstract
Background: Acute pharyngitis is one of the most frequent consultations to the general practitioner and in most
of the cases an antibiotic is prescribed in primary care in Spain. Bacterial etiology, mainly by group A beta-
hemolytic streptococcus (GABHS), accounts for 10-20% of all these infections in adults. The purpose of this study is
to assess the impact of rapid antigen detection testing (RADT) to identify GABHS in acute pharyngitis on the
utilization of antibiotics in primary care.
Methods/design: Multicentric randomized controlled trial in which antibiotic prescription between two groups of
patients with acute pharyngitis will be compared. The trial will include two arms, a control and an intervention
group in which RADT will be performed. The primary outcome measure will be the proportion of inappropriate
antibiotic prescription in each group. Two hundred seventy-six patients are required to detect a reduction in
antibiotic prescription from 85% in the control group to 75% in the intervention group with a power of 90% and a
level of significance of 5%. Secondary outcome measures will be specific antibiotic treatment, antibiotic resistance
rates, secondary effects, days without working, medical visits during the first month and patient satisfaction.
Discussion: The implementation of RADT would allow a more rational use of antibiotics and would prevent
adverse effects of antibiotics, emergence of antibiotic resistance and the growth of inefficient health expenses.
Trial registration: ISRCTN23587778
Background
Acute pharyngitis is frequently seen in primary care for
which uncertain etiology may result in inappropriate
management. Acute pharyngitis includes rhinitis, the
most common cause of visit in primary care in Spain
[1]. Most pharyngotonsillitis are viral in origin while
group A b-hemolytic Streptococcus (GABHS) is the
most common bacterial cause of acute pharyngitis,
accounting for approximately 15% to 30% of the cases
in children and 5% to 15% of cases in adults [2].
GABHS is the only commonly occurring form of acute
pharyngitis for which antibiotic therapy is indicated [3].
Nonetheless, a total of 78-98% of adults with acute
pharingytis is treated with antibiotics, especially if sore
throat is present [4,5]. Pharyngeal infection is also a
frequent cause of absenteeism, with an estimated aver-
age of 6.5 days of sick leave per episode [2,6]. In strep-
tococcal pharyngitis, antibiotic treatment shortens the
transmission and dissemination of GABHS in the com-
munity, reduces the symptomatology compared to the
non treated group by a mean of 16 hours and prevents
suppurative complications. According to the Cochrane
review, for each 100 patients treated with antibiotics
compared to the placebo assigned group, one case less
of rheumatic fever, two cases less of acute otitis media
and 3 cases less of quinsy are produced [7,8].
Overuse of antibiotics can lead to side effects and
emergence of antibiotic resistance [9]. The main reason
for antibiotic overprescription in acute pharyngitis is the
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nosis. In addition, physicians often believe that patients
expect an antibiotic and, in case of doubt, general prac-
titioners are more prone to prescribe antibiotics. In
Spain, rapid antigen detection tests (RADT) are seldom
used in general practice and physicians still rely on the
Centor criteria -fever, tonsillar exudates, tender vertical
nodes, and/or absence of cough- for prescribing antibio-
tic therapy [10]. Sore throat culture is the gold standard
for the diagnosis of streptococcal pharyngitis. However,
the delay in obtaining results makes its performance
useless in clinical practice.
Over the last years, low-cost and rapid immunological
techniques targeting the detection of GABHS antigens
have been developed for use in the clinical setting. Their
high specificity (>95) make the probability of obtaining
false positive results very low [11-13]. A recent paper
p u b l i s h e di nG r e e c es h o w st h a tt h eu s eo ft h e s et e s t s
can reduce the prescription of antibiotics in pharyngo-
tonsillitis in children [14]. However, very few studies
have been carried out to know the impact of RADT on
the pattern of how general practitioners prescribe anti-
biotics for patients with pharyngotonsillitis in adults.
Methods/Design
Objectives
The main objective of this investigation is to assess the
impact of the RADT in adults with acute pharyngitis on
the percentage of antibiotics prescribed by general
practitioners
The secondary objectives are:
a. To describe the antibiotics prescribed.
b. To describe GABHS resistance to the antibiotics
prescribed.
c. To assess clinical recurrence within the first
month.
Design
Multicenter randomized clinical trial designed to com-
pare antibiotic prescription in patients with acute phar-
yngitis in two groups of physicians, one with the use of
RADT and the other without these tests.
Setting
The trial will be conducted in Primary Health Care Cen-
ters in Catalonia (Spain) in which the clinical history
records are accessed electronically.
Participants
Study population
Eligible patients will be consecutively selected by general
practitioners. All patients who agree to participate will
be asked to provide written informed consent and an
informative sheet of the study.
Inclusion criteria
1. Men and women aged 14 to 60 years.
2. More than one symptom of acute pharyngitis, such as
fever, sore throat, tonsillar exudates, tender cervical
nodes and/or absence of cough.
Exclusion criteria
1. Patients who do not consent to participate.
2. Patients younger than 14 or older than 60 years of
age.
3. More than five episodes of pharyngitis over the last
year.
4. Immunosuppressed condition, such as active neo-
plasm, acquired immunodeficiency syndrome or recep-
tion of chemotherapy, radiotherapy, corticosteroids and/
or immunosuppressive therapy.
5. Heart valve disease.
6. Rheumatic fever.
7. Episode of pharyngitis treated with antibiotics in the
previous fifteen days.
8. Pharyngitis of gonococcal etiology.
9. Tonsillectomy.
Intervention
Participating primary health care centers will be rando-
mized to the intervention or to the control arm of the
study. Physicians allocated to the intervention group will
use the RADT and those assigned to the control group
will make the diagnosis of streptococcal pharyngitis with
only clinical criteria. Treatment will be decided upon by
the general practitioners in both groups, including
antithermic drugs, non-steroidal anti-inflammatory
drugs, corticosteroids, antibiotic therapy or none.
Samples will be taken by the family physicians who
will be previously trained to perform the technique
correctly with vigorous rotation of the tonsils and the
posterior pharynx without touching the tongue, teeth
or gums. RADT will be undertaken with all the sam-
ples with the OSOM StrepA (Genzyme) following the
manufacturer’s instructions. The other sample will be
sent to the Department of Microbiology of the two
hospitals of the area with AMIES (Copan Innovation,
Italy) as medium. Samples will be seeded on a plate of
blood agar and will be incubated at 37°C in an atmo-
sphere of CO2 at 5% during 48 hours. A culture will
be considered positive for GABHS with a growth of
any number of b-hemolytic colonies, Gram staining
with streptococcal morphology and a catalase negative
test with posterior identification with an automated
panel for WIDER Gram positive cocci (Soria Mel-
guizo). Results will be confirmed with posterior sero-
grouping with the Streptococcal Grouping Kit (Oxford,
UK). The culture will be considered negative after
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tic colonies.
Outcome measures
Primary outcome: proportion of inappropriate antibiotic
prescription, use of antibiotic treatment, use of RADT,
RADT result, and culture result.
Secondary outcomes
- Intervention arm only: RADT result.
- Both intervention and control groups:
a. Age, sex, clinical symptoms (fever, sore throat,
tender cervical nodes, absence of cough), specific
antibiotic treatment, culture result, antibiotic
resistance, side effects, days without working,
change of antibiotic, and medical visits within
the first month.
b. Patient satisfaction. Patients will be required
to score the degree of satisfaction, from 0 (no
satisfaction at all) to 10 (very satisfied), for the
following items: ease of obtaining a visit the day
the patient wants, duration of the visit, doctor
clinical ability, doctor kindness, doctor predispo-
sition to listen, the way the problem is solved,
the feeling of being in “good hands”, and overall
satisfaction with the doctor. Patients will be
asked if they have been attended by their usual
doctor or not and if they would recommend the
attending doctor to a friend or relative. The
open questions include: What is the most satisfy-
ing aspect of the visit? What is the worst aspect
of the visit? Would you like to make any com-
ment on anything else?
Ascertainment of visits
Baseline data collection
The baseline questionnaire at the clinical practice will
include age, sex, clinical symptoms, specific antibiotic
treatment, use of RADT and RADT result.
Follow-up data collection
￿ 48-72 h data collection by means of a phone call that
will include side effects, days without working, and
change of antibiotic or not.
￿ Three-week data collection: The questionnaire will
include the number of visits, if there has been any com-
plication, culture result and antibiotic resistance to
GABHS if the culture is positive.
￿ The satisfaction interview will be given one month
after the baseline visit.
Sample size
Two hundred seventy-six patients are required in each
arm to detect a reduction of 10% in antibiotic prescrip-
tion from 85% in the control group to 75% in the inter-
vention group, assuming a rate of 85% of prescription in
the control group, allowing 10% for losses in the follow-
up visits, with a power of 90% and a level of significance
of 5% (2-sided) and performance values of the RADT
given by the manufacturer.
Randomization
The unit of randomization will be the primary health
care center, which will be allocated to the control or
intervention group by a random sequence generated by
a computer program. This unit of randomization will be
taken into account in order to minimize contamination
between these two groups. It may not be appropriate to
randomize individuals since patients who attend the
same primary health care center may be treated in the
same way. Patients who meet the inclusion criteria will
be consecutively selected by the participating physicians
and allocated to the treatment group corresponding to
the center.
Blinding
It is not possible to blind participants, patients or doc-
tors. Data will be analyzed blinded to treatment group
allocation.
Withdrawals
Patients will be free to withdraw from the study at any
time. For obtaining the patient satisfaction data the
patients will be phoned at least five times in three differ-
ent timetables before being considered as withdrawal.
Analysis
Data will be analyzed in accordance with CONSORT
guidelines. The primary end point for the trial will be at
baseline and at three weeks (prescription or not of anti-
biotic, RADT use and result, and culture result).
Descriptive statistics of the outcome measures will be
performed as well as baseline characteristics and clinic
measures, calculating means and standard deviations or
percentages, with 95% confidence intervals at each
assessment for all the patients and for each group. Chi-
square tests will be carried out to assess the impact of
RADT on the percentage of antibiotic prescription in
the intervention and control arms. For assessing the
cost-effectiveness study of RADT direct costs such as
antibiotics prescribed, RADT costs, and number of fol-
low-up visit and indirect costs such as sick leave days
will be taken into account. The different antibiotics pre-
scribed, the GABHS resistance rates, the clinical recur-
rences and the clinical criteria will also be determined
to assess the secondary objectives. The level of signifi-
cance of all models will be set at 5%. Statistical analysis
will be carried out with SPSS v. 15 (SPSS Inc., Chicago,
IL) and the SAS v. 9.1.3 for Windows (SAS Institute
Inc., Cary, NC, USA).
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We do not believe that the participants will be exposed
to excessive risk by participation in this study since the
visit schedule dictated by the protocol is similar to that
undertaken in daily clinical practice. Neither do we fore-
see any risk to the patients in obtaining the pharyngeal
sample.
Study limitations
Acute pharyngitis is a very common process and we will
be able to obtain the sample size required in this proto-
col without difficulty. In addition, the protocol is
adapted to the way in which primary care physicians
work and therefore implies neither ethical nor legal pro-
blems for its undertaking in our setting. The only differ-
ence with the usual practice will be the performance of
RADT and the collection of the sample for culture.
However, both procedures are relatively rapid and sim-
ple and are widely used in other countries. We hope
there will not be any logistic problems with the submis-
sion of samples from the health care centers to the
l a b o r a t o r yf o rc u l t u r es i n c ew ew i l lb ep e r s o n a l l y
responsible for this task. There are no major differences
in the GABHS detection technique in the different
laboratories of our setting and thus, no bias in this
sense is expected. Centers and practitioners willing to
participate may be more motivated professionals and
will more likely to follow current guidelines and follow
better clinical practice. This aspect could reduce the
impact of the results obtained in relation to the optimi-
zation of treatment of acute pharyngitis with RADT. We
do not expect many dropouts since the protocol is very
similar to usual practice.
Ethical and organizational review
The study will be conducted according to guidelines of
the Helsinki Declaration and the Good Clinical Research
Practice. The Project has been approved by the Ethical
and Clinical Research Committee of the Jordi Gol Insti-
tute of Research in Primary Health Care. The certificate
number is P06/03.
Informed consent: The information will be provided
orally as well as written. Study subjects will have suffi-
cient opportunity to ask questions regarding study
details. Informed consent follows the guidelines of Hel-
sinki Declaration and the rules of Title I, Article 12 of
the Spanish Royal Decree 561 of the 16th April 1993
Data confidentiality: Individual data will be coded to
ensure anonymity. Only researchers and monitors will
have access to the data.
Discussion
This article presents a detailed description of a rando-
mized clinical trial designed to explore the impact of
RADT on antibiotic prescribing in acute pharyngitis in
adults. The trial proposed is sufficiently powered and, to
the best of our knowledge, the first to allow conclusions
on the effect of RADTs in adults with pharyngitis. Pharyn-
g o t o n s i l l i t i si sav e r yp r e v a l e n td i s e a s ea n di so n eo ft h e
most frequent causes of medical visits in primary care.
Many patients in our country visit the physician in search
of antibiotic prescription since they believe that this is the
treatment of choice, particularly among patients with mul-
tiple disease recurrence. In other cases, patients seek
home remedies or go directly to the pharmacy to obtain
medications to alleviate the sore throat that accompanies
pharyngitis. Primary care physicians are aware that when
the patients visit they wish to receive effective treatment
with medications which rapidly alleviate the accompanying
symptomatology and, in many cases, what they want is
treatment with an antibiotic. This is probably the main
reason why physicians in our country mainly prescribe
these medications together with the fact that it is clinically
difficult to distinguish streptococcal from viral etiology.
We believe that this clinical trial will be of great use to
know whether the RADT are truly effective in reducing
the percentage of antibiotic prescription in our setting.
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